Sign in
CompletedNo phase

MiMBa Pregnancy Registry

Key facts

Who runs it
Liverpool School of Tropical Medicine
Where
Burkina Faso and Kenya2 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
15,391 people enrolled
Started
22 Feb 2021
Ended
31 Dec 2025
Type of study
Observational, 2 groups
Record updated
14 August 2026

Who can take part

Age
15 years to 49 years
Sex
Women only
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Pregnant or women of childbearing age (15-49 years); Resident within the defined catchment area. Residency status will be defined as having resided in the area for at least four months; Willingness to attend antenatal care and deliver in the study area; Willingness to give informed consent (and assent for non-pregnant WOCBAs under 18 years of age)

Who cannot take part

  • Refusal to participate or be followed up to the end of pregnancy. • Any medical, psychiatric, or social condition that would interfere with the ability to provide an accurate medical or drug history or the volunteer's ability to give informed consent (e.g. mentally disabled patients)

Where is this trial?

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The MiMBa (Malaria in Mothers and Babies) Pregnancy Registry aims to generate robust evidence on the safety of a range of antimalarials when used in pregnancy, particularly in the first trimester. This will be a multi-country observational study and will be deployed in several field sites in Africa.

The 2 groups in the trial

  • Pregnant Women exposed to antimalarials during pregnancy

    Pregnant women will be followed up prospectively. In certain sites, women of childbearing age (15-49 years) will be enrolled prior to pregnancy to ensure early pregnancy detection. Pregnancy and infant outcomes will be assessed systematically and recorded.

  • Pregnant Women unexposed to antimalarials during pregnancy

    Pregnant women will be followed up prospectively. In certain sites, women of childbearing age (15-49 years) will be enrolled prior to pregnancy to ensure early pregnancy detection. Pregnancy and infant outcomes will be assessed systematically and recorded.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Pregnancy Registry to Assess the Safety of Antimalarial Use in Pregnancy
Record updated
14 August 2026